- Home
- MNPR vs JMSB Comparison
MNPR vs JMSB Comparison
Compare MNPR & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- JMSB
- Stock Information
- Founded
- MNPR 2014
- JMSB 2005
- Country
- MNPR United States
- JMSB United States
- Employees
- MNPR N/A
- JMSB N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- JMSB Major Banks
- Sector
- MNPR Health Care
- JMSB Finance
- Exchange
- MNPR Nasdaq
- JMSB Nasdaq
- Market Cap
- MNPR 244.1M
- JMSB 268.9M
- IPO Year
- MNPR 2019
- JMSB N/A
- Fundamental
- Price
- MNPR $39.59
- JMSB $14.44
- Analyst Decision
- MNPR Strong Buy
- JMSB
- Analyst Count
- MNPR 5
- JMSB 0
- Target Price
- MNPR $59.50
- JMSB N/A
- AVG Volume (30 Days)
- MNPR 27.1K
- JMSB 30.2K
- Earning Date
- MNPR 05-08-2025
- JMSB 04-28-2025
- Dividend Yield
- MNPR N/A
- JMSB 1.75%
- EPS Growth
- MNPR N/A
- JMSB 233.33
- EPS
- MNPR N/A
- JMSB 1.20
- Revenue
- MNPR N/A
- JMSB $53,688,000.00
- Revenue This Year
- MNPR N/A
- JMSB N/A
- Revenue Next Year
- MNPR N/A
- JMSB N/A
- P/E Ratio
- MNPR N/A
- JMSB $12.03
- Revenue Growth
- MNPR N/A
- JMSB 38.38
- 52 Week Low
- MNPR $1.72
- JMSB $13.81
- 52 Week High
- MNPR $54.30
- JMSB $26.52
- Technical
- Relative Strength Index (RSI)
- MNPR 57.10
- JMSB 33.48
- Support Level
- MNPR $26.06
- JMSB $13.99
- Resistance Level
- MNPR $40.90
- JMSB $15.46
- Average True Range (ATR)
- MNPR 4.78
- JMSB 0.94
- MACD
- MNPR 0.64
- JMSB -0.07
- Stochastic Oscillator
- MNPR 84.89
- JMSB 18.58
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc provides banking services. The company offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.